Back to Walleye Capital LLC Walleye Capital LLC

QNCX

4 quarters

Position history for Walleye Capital LLCWalleye Capital LLC's holdings in QUINCE THERAPEUTICS INC

No. Walleye Capital exited its QNCX (Quince Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 75,694 shares worth $168,000. Walleye Capital first reported QNCX in Q4 2021 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.7M

Total Shares Change

-137,166

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q3
Latest
Exited
0
-100.0%
$00.0%$266.00
0
2022-Q2
New
75,694
-
$168,0000.0%$444.00
31
2022-Q1
Exited
0
-100.0%
$00.0%$1,238.00
0
2021-Q4
New
137,166
-
$1.7M0.1%$2,524.00
36

Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used